News

Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare setup: quality names trading in single-digit and low-double-digit territory while still throwing off cash, growing earnings, and reaffirming guidance. For retail investors scanning for value, the sub-$30 shelf in healthcare currently offers exposure to a pending strategic ... 3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now

Liquidia has surged 129.7% so far in 2026 as Yutrepia gains traction, driving strong sales, profitability and higher earnings estimates.

Protagonist shares rise as rusfertide nears an FDA decision and Icotyde adds milestone payments, royalties and broader pipeline momentum.

Generate an immediate income that you keep regardless, plus the opportunity to buy the stock cheaper should its price fall far enough.

US markets are set for a mixed open on Tuesday, with technology stocks expected to come under pressure after Samsung delivered record quarterly profits that still failed to satisfy investors, raising fresh questions about AI valuations. Nasdaq futures were down 1.1% ahead of the opening bell,...

Replacing $1,500 a month in portfolio income looks simple until yield enters the equation. At a 3.5% yield, you need roughly $514,000 invested. At 6%, the target falls to $300,000. At 10%, it drops to $180,000. Those numbers seem to reward the highest-yielding portfolio, but the real question is what you may have to give ... The $1,500-A-Month Portfolio: Conservative, Moderate, And High-Yield Paths Compared

7.47am: Shell gives pre-results update Shell says stronger trading in its integrated gas business and improved refining margins should support second-quarter performance, although production has been hit by disruption to output from Qatar following the Iran war. Ahead of second-quarter...

Before the share price caught on, the drugmaker was dealing with a problem most companies only dream of, and it was the clearest sign a surge was building.

A retiree who starts with a 10% dividend yield can collect far more income on day one than someone earning 3.5%. Twenty years later, the tables may have turned. One income stream stayed flat while inflation chipped away at its buying power. The other kept growing year after year until it was paying dramatically more. ... Double Your Retirement Income in a Decade. Here’s How.

Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, are worth a look.

The personal saving rate was 3.0% in May 2026, while average annual household expenditures reached $78,535 in the 2024 Consumer Expenditure Survey. That gap helps explain why the income-ladder question keeps surfacing: what does it actually take to manufacture a paycheck from a portfolio when wages alone fall short? The math is unforgiving but simple. ... The Income Ladder: What It Takes To Go From $250 To $5,000 A Month

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.

Johnson & Johnson stock is Monday's IBD Stock Of The Day. The medical bellwether will report its June-quarter earnings next week.

While investors fixate on slowing elective surgeries, a powerful, non-obvious growth engine is accelerating inside the company's U.S. business.

JNJ's Q2 MedTech results will test whether cardiovascular, surgery and vision strength can offset ongoing China VBP headwinds and sustain growth.

ABBV's Q2 spotlight is on Skyrizi and Rinvoq as rising immunology sales aim to offset Humira's decline ahead of July 31 earnings.

Three under-the-radar dividend stocks with solid returns, low debt and room to grow.

A retiree with $500,000 can buy a high-yield income fund showing a 12% distribution rate today and collect $60,000 in the first year if the payout holds. That same $500,000 spread across quality dividend growers paying 3.5% generates just $17,500 in year one. The bigger check feels smart initially, but the math can turn against ... Why A Low-Yield Dividend Portfolio Could Pay More Than A High-Yield Portfolio In Retirement

These three healthcare stocks provide stability, relatively high dividend yields, and consistent growth.

US stocks are predicted to see a mixed start on Monday, with investors rotating back into technology shares after a softer-than-expected jobs report last week eased concerns that the Federal Reserve could raise interest rates again. Nasdaq futures were 1.1% higher ahead of the first trading...

8.39am: Airlines and pubs in good mood Shares in easyJet have flown almost 10% higher to 610p but are still well below the 690p potential offer price. Sector peer Jet2 is up 3.8% too, while long-haul peer IAG has risen 2.1%. The FTSE 100 and FTSE 250 are both on the front foot, up...

Investors continued to pump money into select companies backed by business developments rather than broad market trends.

Johnson & Johnson (NYSE:JNJ) presented new real-world and clinical data on IMAAVY (nipocalimab-aahu) for generalized myasthenia gravis at the European Academy of Neurology Congress. The data highlighted improved outcomes in patients treated earlier in their disease course and sustained symptom control even after common infections. Additional pregnancy safety monitoring and ongoing trials point to potential use in hard-to-treat and at-risk patient groups beyond the current label. For...

California’s median household income landed at $100,600 in 2024, according to Census data compiled by the St. Louis Fed. That is the number a portfolio has to replace to hand a Golden State family the same paycheck without anyone clocking in. The wrinkle: California’s 2024 regional price parity was 110.7, meaning prices were about 10.7% ... A Dividend Portfolio That Out-Earns the Average California Family

Five hundred dollars a month is not enough to replace a paycheck, but it can cover a real bill: a used-car payment, a utility-heavy month, or a meaningful slice of grocery spending. This article builds around a $6,000 annual income stream produced entirely by a portfolio, with no planned withdrawals from principal. The capital required ... How To Turn A Portfolio Into $500 A Month Without Chasing Dangerous Yields

We recently published Jim Cramer’s Biggest Winners to Buy: Top 20 AI & Other Stocks He Got Right in 2026. Johnson & Johnson (NYSE:JNJ) is one of the stocks discussed by Jim Cramer. Healthcare giant Johnson & Johnson (NYSE:JNJ)’s shares are up by 68% over the past year and by 26% year-to-date. The firm reported […]

A worker earning $80,000 full time who wants to drop to a 20-hour-a-week role paying roughly $40,000 faces one math problem: the portfolio must generate the missing $40,000 a year. Bridge income can be built across several yield tiers, and the choice between them determines how much capital is required, how much risk is assumed, ... The Portfolio That Lets You Go Part-Time Five Years Early

Eli Lilly (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ) just reported Q1 2026 results that read like two different playbooks for winning in healthcare. Lilly is riding a GLP-1 wave. JNJ is proving that a wide, refreshed portfolio can still compound. Both raised guidance and both are worth putting side by side right now. GLP-1 Fireworks ... Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly

A $750,000 portfolio at a 5% yield produces $37,500 a year. That is the number most dividend investors repeat. It is also the number they never actually deposit, because the IRS, Medicare, and the state they retired to all get paid first. Here is the gross math at four common yield levels on a $750,000 ... What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality

Medicare is not free, and the bill arrives every month for the rest of your life. The standard Part B premium in 2026 is $202.90 per month, which works out to roughly $2,435 a year per enrollee. Add Part D, a Medigap policy, and the occasional out-of-pocket charge, and most retirees end up writing checks ... What Happens When Medicare Premiums Are No Longer Your Problem?